![conference banner](/images/conference-banner.jpeg)
Abstract
Purpose: Myocardial infarction is a common cardiovascular disease. MicroRNA-16-5p (miR-16-5p) was upregulated in heart and kidney hypoxia/reoxygenation (H/R) injury. However, the role of miR-16-5p in myocardial infarction injury is still unclear.
Methods: Human adult ventricular cardiomyocytes (AC16) were treated with ischemia/reperfusion (H/R). The miR-16-5p level was evaluated through real-time PCR. The activity of lactate dehydrogenase (LDH) and creatine kinase-MB (CK-MB) was detected via LDH and CK-MB monitoring kits. Cell viability was examined with 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetra-zolium bromide (MTT) assay. Western blotting was used to analyze the protein levels. The luci-ferase report assay confirmed the relative luciferase activity.
Results: miR-16-5p was elevated in H/R-treated AC16 cells. miR-16-5p overexpression and knockdown were carried out. miR-16-5p knockdown repressed cell apoptosis, attenuated LDH and CK-MB activities, and enhanced cell viability in H/R-treated AC16 cells. Moreover, miR-16-5p knockdown promoted angiogenesis in human microvascular endothelial cells (HMVEC), causing elevation of vascular endothelial growth factor (VEGF), insulin receptor substrates 1 (IRS1), minichromosome maintenance complex component 2 (MCM2) and proliferating cell nuclear antigen (PCNA) protein levels. Moreover, miR-16-5p was testified to target IRS1. IRS1 silencing alleviated miR-16-5p knockdown-mediated inhibition of apoptosis in AC16 cells.
Conclusion: miR-16-5p knockdown increased cell viability and angiogenesis, as well as inhibited cell apoptosis by increasing IRS1. These findings indicated that miR-16-5p knockdown may be a new therapeutic target for myocardial infarction.
Keywords: miR-16-5p, IRS1, apoptosis, angiogenesis, myocardial infarction, vascular endothelial growth factor, cardiovascular disease.
[http://dx.doi.org/10.1161/01.CIR.101.25.2981] [PMID: 10869273]
[PMID: 31002154]
[http://dx.doi.org/10.1161/CIR.0000000000000133] [PMID: 25249586]
[PMID: 28121344]
[http://dx.doi.org/10.1056/NEJMoa1805971] [PMID: 30145934]
[http://dx.doi.org/10.1186/1476-4598-12-30] [PMID: 23617834]
[PMID: 31091849]
[PMID: 20163779]
[PMID: 25922707]
[http://dx.doi.org/10.1016/j.ijcard.2012.12.074] [PMID: 23347612]
[http://dx.doi.org/10.1186/1746-1596-9-89] [PMID: 24885383]
[http://dx.doi.org/10.1161/CIRCRESAHA.111.244442] [PMID: 22052914]
[http://dx.doi.org/10.1038/nature11919] [PMID: 23426265]
[http://dx.doi.org/10.1084/jem.20101547] [PMID: 21383058]
[http://dx.doi.org/10.1038/nm.1880] [PMID: 18931683]
[http://dx.doi.org/10.1093/carcin/bgs333] [PMID: 23104180]
[http://dx.doi.org/10.1111/febs.12037] [PMID: 23083510]
[PMID: 26885038]
[http://dx.doi.org/10.1038/srep27945] [PMID: 27297958]
[http://dx.doi.org/10.1371/journal.pone.0070644] [PMID: 23967079]
[http://dx.doi.org/10.1128/MCB.00260-06] [PMID: 17030631]
[http://dx.doi.org/10.1006/bbrc.1996.0500] [PMID: 8607861]
[http://dx.doi.org/10.1016/S0002-9440(10)62058-5] [PMID: 16127164]
[http://dx.doi.org/10.1093/jmcb/mjs049] [PMID: 22935141]
[http://dx.doi.org/10.1167/iovs.10-6816] [PMID: 21666240]
[http://dx.doi.org/10.2337/db13-0095] [PMID: 24159000]
[http://dx.doi.org/10.1532/hsf.2079] [PMID: 30802192]
[PMID: 30964183]
[http://dx.doi.org/10.1002/jcp.28291] [PMID: 30883744]
[http://dx.doi.org/10.1016/j.ijcard.2019.11.090] [PMID: 31757654]
[PMID: 31173319]
[http://dx.doi.org/10.1159/000495173] [PMID: 30439699]
[http://dx.doi.org/10.1038/s41419-019-1734-7] [PMID: 31235686]
[http://dx.doi.org/10.1016/j.ejphar.2019.172449] [PMID: 31207208]
[http://dx.doi.org/10.1080/10717544.2019.1628117] [PMID: 31210063]
[PMID: 28656082]
[http://dx.doi.org/10.1016/j.biopha.2016.03.007] [PMID: 27133044]